Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Russo Rene Create: Alert

All | News | Filings
Date FiledTypeDescription
08/18/2023 4 Russo Rene (CEO) has filed a Form 4 on Xilio Therapeutics, Inc.
Txns: Granted 700,000 options to buy @ $2.785, valued at $1.9M
01/04/2023 4 Russo Rene (CEO) has filed a Form 4 on Xilio Therapeutics, Inc.
Txns: Granted 350,000 options to buy @ $2.69, valued at $941.5k
02/24/2022 4 Russo Rene (CEO AND PRESIDENT) has filed a Form 4 on Xilio Therapeutics, Inc.
Txns: Granted 150,000 options to buy @ $12.66, valued at $1.9M
01/04/2022 4/A Russo Rene (CEO AND PRESIDENT) has filed a Form 4 on Xilio Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $13.83, valued at $1.4M
12/23/2021 4 Russo Rene (CEO AND PRESIDENT) has filed a Form 4 on Xilio Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $13.83, valued at $1.4M
10/25/2021 4 Russo Rene (CEO and President) has filed a Form 4 on Xilio Therapeutics, Inc.
Txns: Granted 50,041 options to buy @ $16, valued at $800.7k
10/21/2021 3 Russo Rene (CEO and President) has filed a Form 3 on Xilio Therapeutics, Inc.
08/09/2021 4 Russo Rene (Director) has filed a Form 4 on Adagio Therapeutics, Inc.
Txns: Granted 35,593 options to buy @ $17, valued at $605.1k
06/02/2021 4 Russo Rene (Director) has filed a Form 4 on X4 Pharmaceuticals, Inc
Txns: Granted 6,000 options to buy @ $9.5, valued at $57k
06/11/2020 4 Russo Rene (Director) has filed a Form 4 on X4 Pharmaceuticals, Inc
Txns: Granted 3,427 options to buy @ $8.69, valued at $29.8k
06/19/2019 4 Russo Rene (Director) has filed a Form 4 on X4 Pharmaceuticals, Inc
Txns: Granted 3,427 options to buy @ $14.75, valued at $50.5k
03/09/2018 4 Russo Rene (President and CEO) has filed a Form 4 on Arsanis, Inc.
Txns: Granted 160,000 options to buy @ $17.34, valued at $2.8M
11/15/2017 3 Russo Rene (See Remarks) has filed a Form 3 on Arsanis, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy